Based on our findings, the relationship between UGT2B17 and cancer progression appears even more complex than originally thought, with a differential localisation of the protein in tumour cells compared with normal glands, and a complex transcriptional regulation dependent on alternative promoters and extensive alternative splicing events. Here, UGT2B17 is linked to neoplasm.